Cosmo N.V.

LSE:0RGI.LHealthcare

——At close · Market cap — · Next earnings Wed 24 Mar

0RGI.L · Income statement · TradingHolo

EUR millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	60.9	65.1	102.1	92.8	266.8	104.9	−60.7%
Cost of revenue	27.6	33.0	40.5	39.3	45.4	56.1	+23.6%
Gross profit	33.3	32.1	61.6	53.4	221.4	48.8	−78.0%
Research & development	13.6	11.4	15.5	18.8	39.9	32.3	−19.1%
Selling, general & administrative	18.7	10.5	20.0	30.8	41.5	27.0	−35.1%
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—
Operating expenses	26.4	2.2	33.5	47.3	72.5	59.3	−18.3%
Operating income	6.9	11.1	28.1	6.1	148.9	(10.5)	−107.0%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.2	—
Interest income	7.6	6.2	6.2	4.0	1.6	1.1	−34.2%
Other income / expense	(13.8)	12.9	(3.6)	(4.6)	4.5	9.6	+113.1%
Pre-tax income	(6.9)	24.0	24.5	1.5	153.4	(0.9)	−100.6%
Income tax	1.0	2.3	7.0	6.3	20.2	2.6	−87.2%
Net income	(7.9)	21.7	17.2	(4.9)	133.2	(3.6)	−102.7%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	(0.2)	0.0	0.0	—
EPS, basic (per share)	(0.55)	1.28	1.05	(0.31)	8.14	(0.23)	−102.8%
EPS, diluted (per share)	(0.55)	1.28	1.05	(0.31)	8.12	(0.23)	−102.8%
EBITDA	6.1	17.8	41.2	19.7	160.5	2.4	−98.5%
Depreciation & amortization	4.3	6.7	13.1	13.6	11.6	12.8	+10.8%
Weighted average shares (shares)	14,470,695	16,904,836	16,425,395	16,105,173	16,418,484	15,969,597	−2.7%
Weighted average diluted shares (shares)	14,471,064	16,904,060	16,425,395	16,105,125	16,417,788	15,969,597	−2.7%
Gross margin	54.7%	49.3%	60.3%	57.6%	83.0%	46.5%	−36.5 pts
Operating margin	11.3%	17.1%	27.5%	6.6%	55.8%	−10.0%	−65.8 pts
Net margin	−13.0%	33.3%	16.9%	−5.3%	49.9%	−3.5%	−53.4 pts

EUR millionsUpdated 31 Dec 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

Statements are reported in EUR; the shares trade in CHF.